
Try Ageless Review
Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms
Try Ageless is a longevity and metabolic-health telehealth platform offering compounded semaglutide and tirzepatide in three forms — injection, troche, and sublingual drops — the broadest format range in our directory. It's LegitScript Certified with aggressive introductory pricing across all five products. Semaglutide injection starts at $119/month, one of the lowest entry prices we track.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Try Ageless is a solid telehealth option with balanced features and pricing.
Try Ageless at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $119/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Try Ageless
Each dimension is scored algorithmically from Try Ageless’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $119/mo, Try Ageless runs about 30% below the $170 median for GLP-1 providers.
Effectiveness25%
7.4/10Try Ageless offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.1/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-03).
Accessibility10%
5.3/10Try Ageless's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.1/10Try Ageless provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Try Ageless review
Last checked 2026-06-03- Confirmed current pricing across 5 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Try Ageless offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Try Ageless's current pricing and active discounts before you decide.
What we like
- LegitScript Certified
- Three compounded forms offered: injection, troche, and sublingual drops — the broadest form-factor range we track
- Publishes the FDA compounded-medication disclaimer
- Among the lowest intro prices we track — semaglutide injection at $119/mo
- Delaware corporate address disclosed
- Longevity and metabolic-health positioning
Watch-outs
- Only introductory pricing shown — refill/maintenance prices not disclosed and may step up
- Pharmacy partner not named (only 'state-licensed pharmacies')
- States-served list not provided — availability depends on your state
- Named medical director not disclosed
- 503A vs 503B compounding designation not specified
- Compounded oral forms (drops, troche) have a weaker evidence base than injectable
Try Ageless: the format buffet of compounded GLP-1
Most telehealth clinics give you one way to take your GLP-1: a weekly shot. Try Ageless gives you three. It sells compounded semaglutide and tirzepatide as injections, as sublingual drops, and as troches (lozenges you let dissolve in your mouth) — five distinct products in all, the widest spread of formats in our directory. If the needle is the thing standing between you and starting, that menu is the reason to look here. If you just want the most proven, lowest-cost option, the answer is still the plain old injection.
How the pricing really works (and what it hides)
The headline is genuinely cheap. Semaglutide injection starts at $119 per month — one of the lowest entry prices we track and well under the $170 category median. Tirzepatide injection runs higher, and the oral formats cost the most: the troche and the drops sit at the top of the range because you're paying for the novelty of swallowing instead of injecting, not for better results.
Here's the catch, and it's the most important sentence in this review: every price Try Ageless publishes is an introductory rate. The site frames each one as a discount off a higher number — 30% off here, 17% off there — and it does not disclose what you pay on refills once that intro tier ends. Your $119 starting price could step up at month two or three. The provider doesn't say, so budget as if it will, and pin them down on the maintenance price before you hand over a card.
- Semaglutide injection — the cheapest entry point, starting at $119/mo
- Tirzepatide injection — higher intro price, the stronger dual-agonist molecule
- Semaglutide drops & tirzepatide drops — sublingual, mid-to-upper price tier
- Semaglutide troche — a dissolvable lozenge, priced at the top of the menu
The oral formats: convenient, but less proven
Be clear-eyed about the drops and troches. The clinical evidence behind GLP-1 weight loss — the big trials you've read about — comes almost entirely from injections. Compounded sublingual and lozenge versions are a convenience play, not a science upgrade. How much active drug actually reaches your bloodstream through the mouth is far less established than with a shot. If you genuinely can't or won't inject, they're a real option worth trying. If you're choosing drops just because needles seem like a hassle, you may be paying more for a weaker bet. Start with the injection unless you have a concrete reason not to.
What's verified, and what Try Ageless won't tell you
On the trust side, there's a solid floor here. Try Ageless is LegitScript Certified with a seal ID we could verify, it publishes the required FDA disclaimer in plain sight — stating that compounded semaglutide and tirzepatide are not FDA-approved and haven't been reviewed for safety, efficacy, or quality — and it lists a real Delaware corporate address in Newark. Prescriptions go through a licensed U.S. clinician, and shipping is included free. For a budget compounding shop, that's more transparency than many peers offer.
But the gaps are real and they're why our verification confidence lands at MEDIUM, not high:
- No pharmacy named. Try Ageless only says 'state-licensed pharmacies' — you can't look up who actually mixes your medication, and it never states whether it uses 503A or 503B compounding.
- No medical director named. Care is 'clinician-guided,' but there's no named physician standing behind the brand.
- No states list. Availability 'depends on your state' with no enumeration — you won't know if you're covered until you start the intake.
- No refill pricing, no refund policy. Both are undisclosed, which compounds the introductory-rate problem above.
Who it's for — and who should skip it
Choose Try Ageless if you want the lowest possible entry price on a compounded injection, or if format flexibility — a non-needle option — is what's been keeping you on the sidelines. The cheap intro shot plus free shipping is a low-commitment way to begin, and the LegitScript certification gives you a verifiable baseline of legitimacy.
Skip it if you need to know your long-term monthly cost up front, if you want a named pharmacy and medical director on the record, or if you're set on brand-name Wegovy or Zepbound — Try Ageless deals only in compounded medication, with no brand option. People who value a fully documented supply chain will be more comfortable with a provider that names its pharmacy.
Bottom line
Try Ageless is an aggressively-priced, LegitScript-certified compounding telehealth shop whose real hook is format variety — injection, drops, and troche — at intro rates that undercut most of the field. The honest trade-off is opacity: introductory-only pricing, an unnamed pharmacy, and no listed medical director. It's a reasonable, transparent-enough place to start cheaply on a compounded GLP-1, as long as you go in knowing the $119 price is a teaser and you confirm the refill cost before you commit. See our scoring methodology for how we weigh price transparency against these disclosure gaps.
Shopping around? PeterMD ($105/month) and Found ($129/month) are the nearest alternatives to Try Ageless in our rankings.
Ready to start with Try Ageless?
Starting at $119/month. See current pricing and start your free consultation.
Alternatives to Try Ageless
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Try Ageless review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Try Ageless?
Starting at $119/month. See current pricing and start your free consultation.